➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: February 28, 2021

DrugPatentWatch Database Preview

Secukinumab - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for secukinumab

Tradenames:	1
Patents:	20
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for secukinumab

Recent Clinical Trials for secukinumab

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Bio-Thera Solutions	Phase 1
Janssen Research & Development, LLC	Phase 1
University of Erlangen-Nürnberg Medical School	Phase 3

See all secukinumab clinical trials

Pharmacology for secukinumab

Mechanism of Action	Interleukin-17A Antagonists

Patent Text Search: US Patents for secukinumab

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Novartis Pharms Corp	COSENTYX	secukinumab	INJECTABLE;INJECTION	125504	001	2016-01-15	Start Trial	CureVac AG (Tubingen, DE)	2032-02-15	RX		search
Novartis Pharms Corp	COSENTYX	secukinumab	INJECTABLE;INJECTION	125504	001	2016-01-15	Start Trial	Pfizer Inc. (New York, NY)	2039-02-26	RX		search
Novartis Pharms Corp	COSENTYX	secukinumab	INJECTABLE;INJECTION	125504	001	2016-01-15	Start Trial	Corning Incorporated (Corning, NY)	2031-10-25	RX		search
Novartis Pharms Corp	COSENTYX	secukinumab	INJECTABLE;INJECTION	125504	001	2016-01-15	Start Trial	Corning Incorporated (Corning, NY)	2033-04-24	RX		search
Novartis Pharms Corp	COSENTYX	secukinumab	INJECTABLE;INJECTION	125504	001	2016-01-15	Start Trial	Novartis AG (Basel, CH)	2039-02-26	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for secukinumab

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Morocco	34646	Start Trial
South Korea	102072013	Start Trial
Taiwan	I618543	Start Trial
Taiwan	201517917	Start Trial
Canada	2905108	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey

Boehringer Ingelheim

Colorcon

McKesson

Harvard Business School

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.